Telefónica, Vithas, and UFV Pioneer Quantum Computing for Cancer Drug Discovery Targeting BRAF V600E Mutation

Telefónica (搜索)搜索该词条, Fundación Vithas (搜索)搜索该词条, and Francisco de Vitoria University (搜索)搜索该词条 (UFV) have launched a pioneering project that uses quantum computing for the intelligent design of cancer (搜索)搜索该疾病 drugs, marking a significant technological milestone in oncology drug development. The initiative specifically targets the BRAF V600E (搜索)搜索该靶点 mutation, an altered protein that drives the uncontrolled growth of cancer cells, by generating molecules that inhibit the action of this protein.

Hybrid Quantum-AI Approach Shows Promise

The multidisciplinary team has developed a hybrid model that combines conventional artificial intelligence with the properties of quantum physics to generate drug candidates with far greater precision and quality than current methods. In the project, a classic neural network called LSTM (Long Short-Term Memory) acts as an "architect" that builds molecules while taking advantage of the broad creative vision of a quantum circuit known as QCBM (Quantum Circuit Born Machine).

This symbiosis makes it possible to obtain a list of high-quality candidate molecules and evaluate them using chemical filters, with the advantage of significantly shortening drug development research times. The work carried out so far has yielded very promising preliminary results, with the molecules obtained improving in virtually all parameters involved in the evaluation of a potential drug.

Addressing Traditional Drug Development Challenges

The discovery of drugs using traditional experimental methods involves long development times and a high rejection rate, as only a very small number of drug candidate molecules make it to the most advanced stages of development. This quantum computing approach represents a significant advance in speeding up the development of critical treatments in oncology and other complex diseases.

The work to develop the project has been coordinated from the Javier Echenique Talent and Technology Center, a new strategic space for advanced innovation created by Telefónica (搜索)搜索该词条 and located in Bilbao, which places Spain at the forefront of applied quantum technologies in Europe.

Expert Perspectives on Quantum Drug Discovery

Juan Cambeiro, Head of Applied Quantum Projects at Telefónica (搜索)搜索该词条 Spain, emphasized the practical applications of quantum computing: "This initiative demonstrates how quantum computing has moved beyond theory to become a tool with real possibilities in sectors such as healthcare, industry, logistics, and banking. At Telefónica, we are committed to putting quantum technology at the service of our customers in a practical way and applying it to real challenges. By combining traditional machine learning techniques with quantum circuits in this project, we are not only reducing research times, but also opening the door to more efficient and accessible medicine."

Ángel Ayuso, corporate scientific director of Vithas (搜索)搜索该词条 and director of the Vithas Foundation, highlighted the clinical significance: "From the Brain Tumor Laboratory, a joint unit of the Francisco de Vitoria University (搜索)搜索该词条 and the Vithas Foundation focused on glioblastoma (搜索)搜索该疾病, we are promoting a strategic line of drug discovery that combines the identification of targets or therapeutic molecules in adult and pediatric primary brain tumors (搜索)搜索该疾病 (gliomas (搜索)搜索该疾病) with the rational design of molecules capable of modulating these targets. In this context, the collaboration with Telefónica (搜索)搜索该词条 and UFV to incorporate quantum computing represents a differential leap forward: it allows us to refine the selection of structures with a higher probability of success and accelerate the path in the preclinical development of more effective and precise treatments."

Technological Innovation and Future Applications

Jorge Plazas, professor at the Higher Polytechnic School of the Francisco de Vitoria University (搜索)搜索该词条, noted the paradigm shift: "The adoption of quantum computing constitutes a paradigm shift in the management and processing of information. At its current stage of development, this technology can already offer tangible advantages in specific areas of application. Characterizing its capabilities, along with expanding its applicability to specific use cases, is a priority line of research for UFV. In this project, these objectives are part of a high-impact inter-institutional effort in the field of health."

This innovation pilot combines Telefónica (搜索)搜索该词条's connectivity and computing capabilities, Vithas (搜索)搜索该词条' clinical experience, and UFV's knowledge of molecular biology to position Spain as a leader in the use of quantum technologies applied to oncology.

Expanding Quantum Healthcare Applications

The initiative builds upon previous collaboration between Telefónica (搜索)搜索该词条 and the Vithas (搜索)搜索该词条 hospital group in quantum computing. During the last edition of Mobile World Congress, both entities presented a pioneering healthcare cybersecurity project that deployed a Quantum Key Distribution (QKD) link via fiber optics to connect the Vithas Madrid Arturo Soria and La Milagrosa hospitals in Madrid in an ultra-secure manner. This "Quantum-Safe" technology, developed in collaboration with the Polytechnic University of Madrid (UPM) and partners such as LuxQuanta and QoolNet, shields critical data including medical records, medical images, and vital sign monitoring from future quantum computing threats.

The project will be showcased at Telefónica (搜索)搜索该词条's stand at the Mobile World Congress (MWC) in Barcelona from March 2 to 5, with a specific presentation scheduled for Wednesday, March 4, from 11:30 a.m. to 12:00 p.m. at Telefónica's Ágora in the round table discussion "Applied Quantum Computing: BIN packing and tumor-inhibiting molecules."